Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Release-regulating dopamine autoreceptors in human cerebral cortex

E Fedele1, G C Andrioli, A Ruelle

  • 1Institute of Pharmacology and Pharmacognosy, University of Genova, Italy.

British Journal of Pharmacology
|September 1, 1993
PubMed
Summary

Human brain dopamine D2 receptors on axon terminals in the mesocortical pathway were identified. These D2 autoreceptors regulate dopamine release, as shown by experiments with quinpirole and (-)-sulpiride.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coronary plaque instability assessed by positron emission tomography and optical coherence tomography.

Annals of nuclear medicine·2021
Same author

Subthalamic nucleus deep brain stimulation on motor-symptoms of Parkinson's disease: Focus on neurochemistry.

Progress in neurobiology·2017
Same author

Evaluating the role of hnRNP-C and FMRP in the cAMP-induced APP metabolism.

BioFactors (Oxford, England)·2015
Same author

Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D.

Neuropharmacology·2013
Same author

GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses.

British journal of pharmacology·2011
Same author

The clinical efficacy of L-DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus.

Cell death & disease·2011

Area of Science:

  • Neuroscience
  • Pharmacology
  • Neurochemistry

Background:

  • The mesocortical pathway is crucial for cognitive functions.
  • Dopaminergic neurotransmission plays a key role in the brain.
  • Autoreceptors on dopaminergic terminals modulate dopamine release.

Purpose of the Study:

  • To investigate the presence and type of dopamine autoreceptors on human mesocortical pathway axon terminals.
  • To characterize the pharmacological properties of these autoreceptors.

Main Methods:

  • Human neocortical slices were obtained during neurosurgery.
  • [3H]-dopamine labeling and electrical stimulation were employed.
  • Effects of dopamine receptor agonists (quinpirole, SKF 38393) and antagonists ((-)-sulpiride) were assessed on tritium overflow.

Related Experiment Videos

Main Results:

  • Quinpirole, a selective dopamine D2 receptor agonist, significantly inhibited stimulated tritium overflow (EC50 = 25 nM).
  • The D1 receptor agonist SKF 38393 showed no effect up to 10 microM.
  • (-)-Sulpiride, a D2 antagonist, effectively antagonized quinpirole's effect (apparent pA2 = 8.26).

Conclusions:

  • Dopaminergic axon terminals in the human mesocortical pathway possess functional D2 autoreceptors.
  • These D2 autoreceptors regulate dopamine release, suggesting a role in modulating neurotransmission.